Problemas pulmonares que se agravan en la esclerodermia difusa

La enfermedad pulmonar intersticial (EPI) es una complicación frecuente de la esclerodermia difusa.

[{"selector":"#anim-ba95eb15-2e25-423b-9d69-c21f8dab99d6 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(-3.552713678800501e-15%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

La fibrosis pulmonar puede provocar la formación de cicatrices y una disminución de la función pulmonar.

[{"selector":"#anim-727e7257-7528-4a1a-b0f5-9550e78db2b5 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(21.874999829338595%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}]

La hipertensión arterial pulmonar (HAP) aumenta la presión en las arterias pulmonares.

[{"selector":"#anim-de2c3808-b485-4ddd-b2e9-1640bf9f488d [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-21.874999829338588%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}]

La dificultad para respirar es un síntoma frecuente cuando hay afectación pulmonar.

[{"selector":"#anim-14bbb300-af42-41fb-a0b9-d93c4b27d8e8 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(-3.552713678800501e-15%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

La tos seca puede ser un síntoma persistente de problemas pulmonares.

[{"selector":"#anim-d25a0e33-3bdc-46f5-9e1a-c4d6ba5aa110 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(21.874999829338595%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}]

El deterioro de la función pulmonar puede limitar la actividad física y la tolerancia al ejercicio.

[{"selector":"#anim-5eb849cf-876c-4e3f-918f-f33b47119bb2 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-21.874999829338588%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}]

La detección y el tratamiento tempranos son fundamentales para el control de las enfermedades pulmonares.

[{"selector":"#anim-a26d86f0-2ac2-4952-b634-1cebce163603 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(21.874999829338595%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}]

La ciclofosfamida ha demostrado ser eficaz para ralentizar el deterioro de la función pulmonar.

[{"selector":"#anim-2ce6a8e6-caeb-4420-af29-fae60aadbdf7 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(-3.552713678800501e-15%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

En los casos más graves, podría considerarse un trasplante de pulmón.

[{"selector":"#anim-1f2e6ecf-d5b2-45d9-87e7-172f693979a9 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-21.874999829338588%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}]

El seguimiento periódico es fundamental para controlar la evolución de la enfermedad pulmonar.

[{"selector":"#anim-aab5dea4-dca3-4f88-86e1-9de502f28db6 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(21.874999829338595%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}]

For More Info

[{"selector":"#anim-0cc0a124-0c86-485b-a733-56d1b34fbf97 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(-3.552713678800501e-15%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]